JSJohan Sundström

Johan Sundström

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Johan Sundström has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Percentile-based probabilistic optimization for systematic and random uncertainties in radiation therapy

    by Albin Fredriksson, Erik Engwall, Jenneke de Jong, Johan Sundström

    Objective Geometric uncertainty can degrade treatment quality in radiation therapy. While margins and robust optimization mitigate these effects, they provide only implicit control over the probability of meeting the clinical goals. The goal of this work is to develop and evaluate a probabilistic optimization framework that explicitly targets a specified probability of clinical goal fulfillment over full treatment courses, while remaining computationally tractable. Approach A probabilistic planning framework using a percentile-based optimization function was formulated. Systematic and random uncertainties were explicitly modeled over full treatment courses. To enable efficient optimization, treatment course doses were approximated using interpolation between a precomputed set of dose distributions. The framework was evaluated on a prostate case treated with volumetric-modulated arc therapy (VMAT) and a brain case treated with pencil beam scanning (PBS) proton therapy. Plans were compared to conventional margin-based and worst-case robust optimization using probabilistic evaluation with randomly sampled simulated treatment courses. Main results For the prostate VMAT case, probabilistic optimization improved organ at risk (OAR) sparing while maintaining target coverage compared to margin-based planning, increasing average OAR goal fulfillment probability by 13.3 percentage points and reducing 90th percentile OAR doses by an average of 3.5~Gy. For the brain PBS case, probabilistic optimization improved target minimum dose passing probabilities (e.g., 84\% vs.~19\% for $D_{95}$) and brainstem core maximum dose passing probability (56\% vs.~2\%), while maintaining comparable or improved OAR sparing compared to worst-case optimization. Significance Percentile-based probabilistic optimization enables explicit and interpretable control over clinical goal fulfillment probabilities. By combining full treatment course modeling with efficient approximate dose calculation, the proposed framework provides a practical approach for incorporating probabilities into treatment planning.


  • Open Access

    Sparse probabilistic evaluation for treatment planning: a feasibility study in IMPT head and neck patients

    by Jenneke I de Jong, Steven J M Habraken, Albin Fredriksson, Johan Sundström, Erik Engwall, Sebastiaan Breedveld, Mischa S Hoogeman

    Objective. Probabilistic evaluation improves the trade-off between target coverage and OAR sparing in IMPT but remains computationally demanding. This study proposes sparse probabilistic evaluation (SPE), a computationally efficient approach integrated into a clinical treatment planning system. Approach. Clinical plans of 20 IMPT head and neck cancer patients treated in 2024 were included. SPE used a predefined setup and range error grid with Monte Carlo (MC) computed dose distributions. Two grid settings were evaluated: the maximum error E max (3 σ or 4 σ ), with σ = ( σ randomerror ) 2 + ( σ systematicerror ) 2 , and the number of setup error points n setup (7, 33, 123). Accuracy and duration of SPE with each grid were evaluated in the calibration group (5 patients). A total of 1000 treatments with normally distributed random ( σ = 1 mm) and systematic ( σ = 0.92 mm) setup and range ( σ = 1.5%) errors were simulated. The dose distribution of the nearest error point in the grid was assigned to each fraction. Probability distributions derived from SPE were compared with those from a reference based on 35 000 MC calculations. Agreement was quantified using the mean percentile error (MPE), the mean absolute difference across percentiles 0.01, 0.02, …, 1. The found optimal grid ( E max = 3 σ, n setup = 33) was applied to the validation group (15 patients). Main results. The median MPE in the calibration group decreased significantly as the number of error points increased from 7 ( t avg = 2 min) to 33 ( t avg = 9 min), with no further improvement between 33 and 123 ( t avg = 27 min) error points. Increasing E max from 3 σ to 4 σ only improved accuracy for values above the 98th percentile. Applying SPE to the validation group resulted in median errors of 0.02 Gy RBE (range: −0.11–0.07) for the 10th percentile of the D 99.8%, CTV distribution and 0.0 Gy RBE (range: −0.14–0.23) for the 95th percentile of the D 0.03cc,SpinalCord Core distribution. Significance. SPE achieves sufficient accuracy while requiring clinically acceptable computation times, paving the way for probabilistic evaluation in clinical practice.


  • Open Access

    The proteomic profile of leisure time physical activity across two decades: implications for future cardiovascular risk and mortality

    by Malin Enarsson, Stefan Gustafsson, Erik Lampa, Tobias Rudholm Feldreich, Sara Beigrezaei, Adam S Butterworth, Sölve Elmståhl, Gunnar Engström, Kristian Hveem, Mattias Johansson, et al.

    Aims: We aimed to (i) investigate associations between leisure time physical activity level cumulated over 20 years and multiple plasma proteins and (ii) explore if proteins significantly associated with physical activity are also associated with risk of imminent myocardial infarction (MI), long-term MI, and mortality. Methods and results: In the cohort Uppsala Longitudinal Study of Adult Men, leisure time physical activity was self-reported at Ages 50, 60, and 70. At Age 70, 720 plasma proteins were analysed in 782 participants with up to 19.3 years of follow-up for MI and 26.3 years follow-up for mortality. In the nested case-cohort study Markers of Imminent Myocardial Infarction, plasma proteins were measured in disease-free individuals from six European cohorts. Cases (n = 420) were those with acute MI within 6 months of a blood draw, with up to four cohort representatives per case (n = 1598). A higher level of leisure time physical activity level was inversely associated with 12 plasma proteins after adjusting for age, education, smoking, and established cardiovascular risk factors (Bonferroni-corrected P < 0.000069). Of these 12 proteins, interleukin-6 was associated with increased incidence of imminent MI [hazard ratio, HR 1.22; 95% confidence interval, CI (1.09–1.37)], tumour necrosis factor receptor superfamily member 11A was associated with increased long-term MI incidence [HR 1.22 (1.01–1.48)] and 11 proteins were associated with increased mortality [HR 1.14–1.30 (1.01–1.42)]. Conclusion: These findings confirm and extend our understanding of how physical activity could assert its beneficial effect on cardiovascular health through proteins involved with modulating inflammatory, immune, and metabolic pathways. Further research is needed to explore the causal mechanisms behind these associations. Lay summary: In this study, we aimed to investigate (i) whether leisure time physical activity level cumulated over 20 years is associated with 720 plasma proteins and (ii) if proteins that are significantly associated with leisure time physical activity level across 20 years in Part 1 are also associated with imminent and long-term risk of myocardial infarction (MI) and mortality.Higher physical activity level over 20 years was inversely associated with 12 plasma proteins involved in inflammatory, immune, and metabolic processes. Several plasma proteins were in turn associated with MI and mortality.Findings confirm and extend our understanding how physical activity could assert its beneficial effect on cardiovascular health via the circulating plasma proteins.


  • Open Access

    Dynamic proton arc treatment planning study for oesophageal cancer

    by Macarena Chocan Vera, Anne-Catherine Wéra, Hamdiye Ozan, Erik Engwall, Viktor Wase, Otte Marthin, Johan Sundström, Sophie Wuyckens, Karin Haustermans, Ana M. Barragán-Montero, et al.


  • Partitioning of multiple brain metastases improves dose gradients in single‐isocenter radiosurgery

    by Johan Sundström, Anton Finnson, Elin Hynning, Geert De Kerf, Albin Fredriksson

    Background: A growing number of cancer patients with brain metastases can benefit from stereotactic radiosurgery (SRS) thanks to recent advances in systemic therapies which have led to improved survival. Meanwhile, selection criteria for SRS treatments are evolving to include patients with increasingly many metastases. With an increasing patient load, single‐isocenter treatments on widely available C‐arm linear accelerators are an attractive option. However, the planning of such treatments is challenging for multi‐target cases due to the island blocking problem, which occurs when the multi‐leaf collimator cannot conform to all targets simultaneously. Purpose: We propose a multi‐target partitioning algorithm that mitigates excessive exposure of normal tissue caused by the island blocking problem. Methods: The proposed algorithm considers an initial set of arc trajectories and divides (partitions) the set of targets per trajectory into smaller subsets to treat with separate back‐and‐forth arc passes, simultaneously optimizing both the target subsets and collimator angles to minimize island blocking. We incorporated this algorithm into a fully automated treatment planning script and evaluated it on 20 simulated patient cases, each with 10 brain metastases and 21 Gy prescriptions. For each case, the script generated a series of volumetric modulated arc therapy (VMAT) plans with increasingly many arcs along the three trajectories. Each such plan was compared to four baseline plans generated with alternative heuristics for distributing targets across arcs. We also evaluated the algorithm retrospectively on six clinical cases. Results: Partitioning significantly improved the gradient index (GI), global efficiency index () and brain compared to simultaneous treatment of all metastases. For example, the average GI improved from 5.9 to 3.3, from 0.32 to 0.46, and normal brain from 49 to 26 between 3 and 9 arcs. The baseline plans improved similarly, but the proposed algorithm was significantly better at utilizing a limited budget of arcs. All target partitioning strategies increased the total number of monitor units (MUs). Conclusions: The dose gradient in single‐isocenter VMAT plans can be substantially improved by treating a smaller subset of metastases at a time. This requires more MUs and arcs, implying a trade‐off between delivery time and plan quality, which can be explored using the algorithm proposed in this paper.


  • Open Access

    Potential toxicity benefit and inter-fraction robustness of proton arc therapy compared to IMPT and VMAT for nasopharyngeal cancer patients

    by B A de Jong, A Maring, Werkman Ci, J Sundström, D Cannavò, A van der Schaaf, D Scandurra, E Engwall, E W Korevaar, G Janssens, et al.

    Objective. Radiotherapy in nasopharyngeal cancer (NPC) patients presents challenges due to proximity of many anatomical structures to the target volume. Furthermore, inter-fractional changes must be considered to assure target coverage. Proton arc therapy (PAT) potentially reduces healthy tissue dose compared to IMPT and VMAT. The impact of PAT on dose to organs-at-risk (OARs), predicted acute-and late radiation toxicities and robust target coverage to inter-fraction changes in NPC patients were investigated. Approach. Robustly optimized PAT plans were compared to clinical VMAT and IMPT plans for 10 NPC patients treated with 70.00 Gy to the primary target (CTV 7000) and 54.25 Gy to the prophylactic lymph nodal area (CTV 5425). Integral body dose and mean and max in 0.03cc dose (D mean and max D0.03cc) in OARs were compared. Normal tissue complication probability (NTCP) values for 22 acute and late radiation-induced toxicities were evaluated. A PAT ‘base approach’ and nine PAT planning approaches to improve PAT inter-fraction robust target coverage were investigated. Target coverage was evaluated on in total 54 weekly repeated CT images (rCTs). Main results. PAT integral dose reduced by on average 55% and 15% compared with clinical VMAT and IMPT, respectively. Compared to IMPT, average D mean and max D0.03cc were significantly reduced in all evaluated neurological structures. Compared to IMPT, in the PAT plans D mean was reduced most in the arytenoids, PCM medius and brainstem by on average 8.0 Gy, 6.4 Gy and 6.1 Gy, respectively and all evaluated NTCP’s for both acute and late timepoint were significantly reduced. Compared with IMPT, PAT base approach target coverage on rCTs was worse. Approaches to improve PAT inter-fraction target coverage were successful, while maintaining the reduction in NTCP compared to IMPT. Significance. Compared to IMPT and VMAT, PAT reduces healthy tissue dose and subsequent estimated toxicity risks in NPC patients. PAT planning approaches to improve inter-fraction robustness were employed successfully, while NTCP benefits of PAT were maintained.


  • Proton arc therapy plan optimization with energy layer pre-selection driven by organ at risk sparing and delivery time

    by Sophie Wuyckens, Guillaume Janssens, Macarena Chocan Vera, Johan Sundström, Dario Di Perri, Edmond Sterpin, Kevin Souris, John A Lee

    Objective. As proton arc therapy (PAT) approaches clinical implementation, optimizing treatment plans for this innovative delivery modality remains challenging, especially in addressing arc delivery time. Existing algorithms for minimizing delivery time are either optimal but computationally demanding or fast but at the expense of sacrificing many degrees of freedom. In this study, we introduce a flexible method for pre-selecting energy layers (EL) in PAT treatment planning before the actual robust spot weight optimization. Approach. Our EL pre-selection method employs metaheuristics to minimize a bi-objective function, considering a dynamic delivery time proxy and tumor geometrical coverage penalized as a function of selected organs-at-risk crossing. It is capable of parallelizing multiple instances of the problem. We evaluate the method using three different treatment sites, providing a comprehensive dosimetric analysis benchmarked against dynamic proton arc plans generated with early energy layer selection and spot assignment (ELSA) and IMPT plans in RayStation TPS. Result. The algorithm efficiently generates Pareto-optimal EL pre-selections in approximately 5 min. Subsequent PAT treatment plans derived from these selections and optimized within the TPS, demonstrate high-quality target coverage, achieving a high conformity index, and effective sparing of organs at risk. These plans meet clinical goals while achieving a 20%–40% reduction in delivery time compared to ELSA plans. Significance. The proposed algorithm offers speed and efficiency, producing high-quality PAT plans by placing proton arc sectors to efficiently reduce delivery time while maintaining good target coverage and healthy tissues sparing.